arrow
Z

Zeyad D. Nassar

South Australian Health and Medical Research Institute
H指数:29
被引数:1,878

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tuning the lipophilicity of a 3,4-dialkoxy-1,8-naphthalimide scaffold to optimise live cell lipid droplet imaging

通过调节3,4-二烷氧基-1,8-萘二甲酰亚胺骨架的脂溶性以优化活细胞脂滴成像

2026-10-010
OAAI
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis

ACSM1和ACSM3调节脂肪酸代谢以支持前列腺癌生长并抑制铁死亡

2024-04-242
PRE
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer

靶向透明质酸介导的运动受体 (HMMR) 可增强前列腺癌对雄激素受体信号抑制剂的反应

2023-09-065
OA
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover

前列腺癌细胞增殖受LDL-胆固醇可用性和胆固醇酯周转的影响

2022-01-1527
OAAI
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition

临床前列腺癌的脂质组学分析揭示了膜脂质组成的可靶向变化

2021-08-0646
OA
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

ELOVL5是前列腺癌中关键且可靶向的脂肪酸延长酶

2021-02-0550
OA
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to Protect prostate tumor cells from ferroptosis

人类DECR1是一种雄激素抑制的生存因子,调节PUFA氧化以保护前列腺肿瘤细胞免受铁死亡

2020-07-20124
OA
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer

细胞外脂肪酸是前列腺癌中脂质合成的主要贡献者

2019-04-0171
OAAI